MedCity News

Report: How Medicaid/SNAP Cuts Could Affect the Economy

Changes in Nurse Staffing Answer Clinician Demands

The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.

By Tomasz Rezik

Events

Check Out the Future of Medtech: A Preview of Device and Diagnostics INVEST Pitch Perfect Finalists

Finalists in the Pitch Perfect contest at INVEST, scheduled for May 20-21 in Chicago at the Willis Tower, span medtech for asthma, diabetic neuropathy, Parkinson's disease, and more. Register today!

By Stephanie Baum

MedCity Influencers

The Workforce is Suffering from Chronic Back Pain — It’s Time for a New Approach

While high-acuity options must remain for those that need stronger interventions, millions more could be benefiting from access to low-acuity or minimal interventions.

By Joseph Brence

Latest News

Hospitals, Health Tech Providers,

Most Healthcare Providers Remain Highly Vulnerable to Ransomware Attacks

About 90% of healthcare organizations are insecurely connected to the internet and running systems vulnerable to exploitation by ransomware gangs, according to new research. It also found that 78% of providers have made ransomware payments of $500,000 or more.

By Katie Adams

BioPharma, Pharma

Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1s

Novo Nordisk gets global rights to Lexicon Pharmaceuticals’ LX9851, an oral small molecule with a first-in-class approach to sparking weight loss. The licensing agreement comes months after Lexicon reported encouraging preclinical data from tests of LX9851 in combination with semaglutide, the main ingredient in Novo Nordisk’s Wegovy.

By Frank Vinluan

MedCity Influencers

How Community Health Programs are Reducing 911 Calls and Helping Patients Before Emergencies

By focusing on prevention, collaboration, and data-driven innovation, community health programs are ensuring resources are used more effectively and patient care is proactive rather than reactive.

By Joe Graw

MedCity Influencers

Bridging the AI Gap in Local Health: Practical Steps for Adoption

By prioritizing staff education, starting small with practical applications, and establishing clear guidelines, local health departments can lay the foundation for sustainable AI adoption. This approach ultimately enhances efficiency, improves health outcomes, and ensures cost-effective care for the communities they serve.

By John Auerbach and Eddie Kirkland

Health Tech, Payers

Startup Launches To Offer Payers an AI-Powered Contact Center Platform

TrampolineAI launched out of Redesign Health to help health plans with their contact centers.

By Marissa Plescia

BioPharma, Pharma

Rare Metabolic Disease That Leads to Childhood Obesity Gets Its First FDA-Approved Drug

Soleno Therapeutics’ Vykat XR is now FDA approved for treating hyperphagia, or excessive hunger, in patients with Prader-Willi syndrome. The once-daily pill is the first approved therapy for this rare disease, a leading cause of childhood obesity.

By Frank Vinluan

Policy, BioPharma, Health Tech

NIH Cuts: A Push for Efficiency or a Blow to US Healthcare Innovation?

The Trump administration recently cancelled billions of dollars in funding to the NIH. Healthcare experts say the funding cuts will delay the pace of medical research in the U.S. — which will not only hamper the commercialization of life-saving treatments, but could also hurt the country’s position as a global leader in healthcare and technology.

By Katie Adams

Providers, Hospitals

MedCity FemFwd: The Link Between Intimate Partner Violence and Health

In this episode, we’re joined by Dr. Audrey Jiricko, senior medical director of women’s health at Intermountain Health. She discusses how the organization is screening women for intimate partner violence.

By Marissa Plescia

MedCity Influencers

Why Playing Nice is a Competitive Advantage

When systems integrate better, every minute saved by removing roadblocks is a minute given back to clinicians and patient care. It’s time for vendors in this space to treat interoperability as a core business strategy rather than a buzzword or another box to check as they’re going through the motions.

By Guillaume Castel

MedCity Influencers

The Challenges Of HCPs Accessing Reliable Online Medicines Information and What Pharma Companies Can Do To Improve Information Sharing

Enhancing the accessibility of trustworthy medicines information and the availability of SRDs while also improving search technologies will ensure HCPs can quickly obtain accurate answers to their specific questions.

By Rich Cooper

Consumer / Employer, Payers

Report: Traditional Drug Costs Outpace Specialty Due to GLP-1 Demand

The annual growth rate of spending for traditional drugs increased from 2.1% in 2021 to 12.8% in 2024, according to Evernorth Research Institute.

By Marissa Plescia

Pharma, BioPharma

FDA Approves First-in-Class GSK Antibiotic for Common Type of Urinary Tract Infection

The FDA approved GSK antibiotic Blujepa as a treatment for uncomplicated urinary tract infections. The drug’s novel mechanism of action addresses a broader range of pathogens and could offer a way to lower the potential for drug resistance.

By Frank Vinluan

MedCity Influencers

Marketing’s Untapped Opportunity in the Medical Product Lifecycle

If marketing’s participation isn't already incorporated into a company's official product development process, they’re missing the boat.

By Chuck Serrin

BioPharma, Startups

Seeing a Better Way for Eye Drug R&D, Character Bio Lands $93M for Two Trials in Dry AMD

Apellis Pharmaceuticals and Astellas Pharma have the first two FDA-approved therapies for geographic atrophy, but Character Biosciences claims its approach could be best in class for treating this advanced form of dry age-related macular degeneration. The biotech's Series B round will finance clinical tests of two programs, each addressing a different stage of the disease.

By Frank Vinluan

Startups, Health Tech, Artificial Intelligence Providers,

Navina Snags $55M for Its Value-Based Care AI Copilot

Navina closed a $55 million Series C funding round led by Goldman Sachs. The company, based in Israel and New York, uses AI to help primary care physicians thrive in value-based care models.

By Katie Adams